Michael Barbella, Managing Editor03.12.22
OEMs took top billing this past week as both Medtronic and Philips drove MPO site traffic.
Medtronic added page views with its Vizient contract deal and fallout from its recall of its TurboHawk Plus System. The world's largest medical device manufacturer reached a deal to add its Touch Surgery Enterprise platform to Vizient's offerings. The artificial intelligence-powered surgical video management and analytics platform for the operating room simplifies recording, analyzing, and sharing surgical video. The fully integrated hardware and software system is connected to the cloud and works with many laparoscopic and robotic scopes to help hospitals digitize their ORs using existing equipment. The system is compatible with Medtronic's Hugo robot-assisted surgery system.
The repercussions of Medtronic's Feb. 4 recall of its TurboHawk Plus directional atherectomy system garnered interest among cyber-readers as well and for good reason—the U.S. Food and Drug Administration deemed the recall a Class I event. TurboHawk Plus consists of a catheter and cutter driver, which are used to remove a blockage from peripheral arteries and improve blood flow. Medtronic recalled the product over design similarities with the HawkOne directional atherectomy system that recently was recalled for correction.
Philips contributed to website viewership too, by releasing new research evaluating its mobile cardiac outpatient telemetry (MCOT) technology for first-line diagnostic ambulatory monitoring. A 12-month study of 1,000 post-cryptogenic stroke patients showed 30-day continuous. monitoring with the company's BioTel Heart MCOT patch followed by an implantable loop recorer (ILR) improved atrial fibrillation detection rates, spotting 4.6 times more patients with Afib than ILR alone. It also helped reduce secondary stroke risk from new anticoagulant use in patients with MCOT patch-detected Afib.
Besides Philips' and Medtronic's latest updates, MPO website visitors also favored posts about the FDA approval of Singapore-based Biobot Surgical's iSR'obot Mona Lisa 2.0, a robotic-assisted transperineal needle-guidance system, and FUJIFILM Sonosite's patent suit against Butterfly Network.
1. Medtronic, Vizient Ink Deal for Touch Surgery Enterprise
2. Philips Releases BioTel Heart MCOT Monitoring Study Data
3. Medtronic's TurboHawk Plus Recall Deemed Class I
Medtronic added page views with its Vizient contract deal and fallout from its recall of its TurboHawk Plus System. The world's largest medical device manufacturer reached a deal to add its Touch Surgery Enterprise platform to Vizient's offerings. The artificial intelligence-powered surgical video management and analytics platform for the operating room simplifies recording, analyzing, and sharing surgical video. The fully integrated hardware and software system is connected to the cloud and works with many laparoscopic and robotic scopes to help hospitals digitize their ORs using existing equipment. The system is compatible with Medtronic's Hugo robot-assisted surgery system.
The repercussions of Medtronic's Feb. 4 recall of its TurboHawk Plus directional atherectomy system garnered interest among cyber-readers as well and for good reason—the U.S. Food and Drug Administration deemed the recall a Class I event. TurboHawk Plus consists of a catheter and cutter driver, which are used to remove a blockage from peripheral arteries and improve blood flow. Medtronic recalled the product over design similarities with the HawkOne directional atherectomy system that recently was recalled for correction.
Philips contributed to website viewership too, by releasing new research evaluating its mobile cardiac outpatient telemetry (MCOT) technology for first-line diagnostic ambulatory monitoring. A 12-month study of 1,000 post-cryptogenic stroke patients showed 30-day continuous. monitoring with the company's BioTel Heart MCOT patch followed by an implantable loop recorer (ILR) improved atrial fibrillation detection rates, spotting 4.6 times more patients with Afib than ILR alone. It also helped reduce secondary stroke risk from new anticoagulant use in patients with MCOT patch-detected Afib.
Besides Philips' and Medtronic's latest updates, MPO website visitors also favored posts about the FDA approval of Singapore-based Biobot Surgical's iSR'obot Mona Lisa 2.0, a robotic-assisted transperineal needle-guidance system, and FUJIFILM Sonosite's patent suit against Butterfly Network.